J&J's HIV Drug Edurant and Other Similar Drugs May Be Effective in Treating Zika Viruses

Researchers with Temple University Health System have found that the Zika virus responds to an HIV drug called rilpivirine, which is marketed by Janssen, a Johnson & Johnson company, as Edurant. In addition, the enzymes targeted by rilpivirine are also found in other viruses similar to Zika, including the viruses that cause dengue fever, yellow fever, West Nile fever, and hepatitis C.